The BETTER-B clinical trial found that patients with COPD and ILDs using mirtazapine for breathlessness vs placebo had slightly increased adverse events and care use. Among patients with chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback